Finanical Statements
Cairo Pharmaceuticals (CPCI.CA) Reports Its Financial Results for The Period From 01/07/2025 to 31/03/2026
Published at 17 May 2026 at 10:43Related stock: CPCI
AI Summary
AI-powered disclosure summary — Coming soon 🔜
Company Name: Cairo Pharmaceuticals
ISIN Code: EGS38391C016
Currency: Egyptian Pound
F/S Period: From 01/07/2025 to 31/03/2026
Net profit: 412,811,945
F/S Period: From 01/07/2024 to 31/03/2025
Net Comparative profit: 352,038,575
Audit Status: Reviewed
Source: Cairo Pharmaceuticals
The Audit Committee Report (5,153 KB)
The Financial Statements (12,000 KB)
ISIN Code: EGS38391C016
Currency: Egyptian Pound
F/S Period: From 01/07/2025 to 31/03/2026
Net profit: 412,811,945
F/S Period: From 01/07/2024 to 31/03/2025
Net Comparative profit: 352,038,575
Audit Status: Reviewed
Source: Cairo Pharmaceuticals
The Audit Committee Report (5,153 KB)
The Financial Statements (12,000 KB)